AGER and triple-negative breast carcinoma: Recently, a RAGE-binding peptide [20] demonstrated a promising inhibitory effect on cancer growth, along with other small-molecule RAGE inhibitors [21] showing potential in suppressing metastasis in triple-negative breast cancer.